Ngala Robert Amadu, Fondjo Linda Ahenkorah, Gmagna Peter, Ghartey Frank Naku, Awe Martin Akilla
Department of Molecular Medicine, School of Medical Science, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana.
Department of Chemical Pathology, University of Cape Coast, Cape Coast- Ghana.
PLoS One. 2017 Jul 21;12(7):e0181613. doi: 10.1371/journal.pone.0181613. eCollection 2017.
Gestational diabetes is a risk factor for perinatal complications; include shoulder dystocia, birth injuries such as bone fractures and nerve palsies. It is associated with later development of type 2 diabetes, the risk of macrosomia and other long-term health effects of infants born to diabetic mothers. The study assesses placental peptides and maternal factors as potential predictors of gestational diabetes among pregnant women.
A total of 200 pregnant women were recruited for the study, 150 pregnant women without pre gestational diabetes including 50 women with low risk factors of diabetes as controls and 50 other pregnant women with pregestational diabetes as control. Fasting blood glucose and the lipid profile were determined by enzymatic methods using Envoy® 500 reagents (Vital Diagnostics, USA). Glycated haemoglobin was assessed using the Cation Exchange resin method. Leptin and the Human Placenta Lactogen were assayed using the Sandwich-ELISA technique. Beta chorionic gonadotrophin, insulin, progesterone and estradiol were determined using chemilumiscence imunoassay technique on MAGLUMI 600 analyzer. Anthropometry, including BMI and blood pressure were also measured.
Fasting plasma glucose (FBG), insulin, insulin resistance, glycated haemoglobin and Human Placenta Lactogen(HPL)were significantly (p<0.0001) increased in the pregestational diabetic women whereas progesterone and estradiol were significantly decreased. In the second trimester however, there was no significant difference (p>0.05) in estradiol, insulin, insulin resistance and HPL between the pregnant women who developed gestational diabetes and those who did not. Leptin, progesterone and FBG were significantly increased in those who developed GDM. The risk of developing gestational diabetes increased with overweight (OR = 1.76, P = 0.370) and family history of diabetes (OR = 2.18, P = 0.282).
Leptin, progesterone, estradiol estimated in this study were increased in the gestational diabetes mellitus women and fairly predicted gestational diabetes in the non-diabetics pregnant women. Obesity, aging and family history of diabetes were strongly predictive of gestational diabetes.
妊娠期糖尿病是围产期并发症的一个危险因素;包括肩难产、骨折和神经麻痹等产伤。它与2型糖尿病的后期发展、巨大儿风险以及糖尿病母亲所生孩子的其他长期健康影响有关。该研究评估胎盘肽和母体因素作为孕妇妊娠期糖尿病潜在预测指标的情况。
共招募200名孕妇参与研究,150名无孕前糖尿病的孕妇,其中50名糖尿病风险因素低的孕妇作为对照,另外50名孕前糖尿病孕妇作为对照。采用Envoy® 500试剂(美国Vital Diagnostics公司)通过酶法测定空腹血糖和血脂谱。使用阳离子交换树脂法评估糖化血红蛋白。采用夹心酶联免疫吸附测定技术检测瘦素和人胎盘催乳素。在MAGLUMI 600分析仪上使用化学发光免疫测定技术测定β绒毛膜促性腺激素、胰岛素、孕酮和雌二醇。还测量了人体测量指标,包括体重指数和血压。
孕前糖尿病女性的空腹血糖(FBG)、胰岛素、胰岛素抵抗、糖化血红蛋白和人胎盘催乳素(HPL)显著升高(p<0.0001),而孕酮和雌二醇显著降低。然而,在孕中期,发生妊娠期糖尿病的孕妇与未发生妊娠期糖尿病的孕妇在雌二醇、胰岛素、胰岛素抵抗和HPL方面无显著差异(p>0.05)。发生妊娠期糖尿病的孕妇瘦素、孕酮和FBG显著升高。超重(OR = 1.76,P = 0.370)和糖尿病家族史(OR = 2.18,P = 0.282)会增加发生妊娠期糖尿病的风险。
本研究中测定的瘦素、孕酮、雌二醇在妊娠期糖尿病女性中升高,并能较好地预测非糖尿病孕妇的妊娠期糖尿病。肥胖、年龄增长和糖尿病家族史是妊娠期糖尿病的强预测因素。